UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · Real-Time Price · USD
276.41
-16.25 (-5.55%)
Oct 22, 2024, 4:00 PM EDT - Market closed
UFP Technologies Market Cap
UFP Technologies has a market cap or net worth of $2.12 billion as of October 23, 2024. Its market cap has increased by 67.45% in one year.
Market Cap
2.12B
Enterprise Value
2.15B
1-Year Change
67.45%
Ranking
Category
Stock Price
$276.41
Market Cap Chart
Since December 1, 1998, UFP Technologies's market cap has increased from $15.40M to $2.12B, an increase of 13,674.48%. That is a compound annual growth rate of 20.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2024 | 2.12B | 61.41% |
Dec 29, 2023 | 1.31B | 47.10% |
Dec 30, 2022 | 893.40M | 68.82% |
Dec 31, 2021 | 529.20M | 51.50% |
Dec 31, 2020 | 349.30M | -5.34% |
Dec 31, 2019 | 369.00M | 66.59% |
Dec 31, 2018 | 221.50M | 9.65% |
Dec 29, 2017 | 202.00M | 9.78% |
Dec 30, 2016 | 184.00M | 8.24% |
Dec 31, 2015 | 170.00M | -2.02% |
Dec 31, 2014 | 173.50M | -0.12% |
Dec 31, 2013 | 173.70M | 44.03% |
Dec 31, 2012 | 120.60M | 25.10% |
Dec 30, 2011 | 96.40M | 27.18% |
Dec 31, 2010 | 75.80M | 96.88% |
Dec 31, 2009 | 38.50M | 29.19% |
Dec 31, 2008 | 29.80M | -24.56% |
Dec 31, 2007 | 39.50M | 36.68% |
Dec 29, 2006 | 28.90M | 153.51% |
Dec 30, 2005 | 11.40M | -35.23% |
Dec 31, 2004 | 17.60M | 100.00% |
Dec 31, 2003 | 8.80M | 95.56% |
Dec 31, 2002 | 4.50M | - |
Dec 31, 2001 | 4.50M | -39.19% |
Dec 29, 2000 | 7.40M | -44.78% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ImmunityBio | 2.47B |
Geron | 2.47B |
CG Oncology | 2.44B |
Addus HomeCare | 2.36B |
Wave Life Sciences | 2.33B |
Tandem Diabetes Care | 2.31B |
Longboard Pharmaceuticals | 2.31B |
SpringWorks Therapeutics | 2.30B |